| Code | Description | Claims | Beneficiaries | Total Paid |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
20,651 |
8,384 |
$454K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,533 |
1,117 |
$144K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20,325 |
8,126 |
$100K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,246 |
1,378 |
$53K |
| 87634 |
|
20,985 |
8,442 |
$48K |
| 87150 |
|
183 |
138 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
724 |
173 |
$8K |
| 87631 |
|
990 |
488 |
$8K |
| 81226 |
|
27 |
27 |
$4K |
| 87501 |
|
315 |
236 |
$1K |
| 81225 |
|
27 |
27 |
$415.41 |
| 81227 |
|
27 |
27 |
$147.08 |
| 81400 |
|
29 |
27 |
$62.03 |
| 81001 |
|
115 |
92 |
$9.82 |